EOM Pharmaceutical Holdings Inc (IMUC)
0.1840
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
EOM Pharmaceutical Holdings Cash from Financing (TTM): 11.96M for June 30, 2018
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
June 30, 2018 | 11.96M |
March 31, 2018 | 11.89M |
December 31, 2017 | 11.86M |
September 30, 2017 | 6.19M |
June 30, 2017 | 8.059M |
March 31, 2017 | 8.411M |
December 31, 2016 | 8.701M |
September 30, 2016 | 12.81M |
June 30, 2016 | 4.534M |
March 31, 2016 | 4.256M |
December 31, 2015 | 18.59M |
September 30, 2015 | 16.42M |
June 30, 2015 | 16.81M |
March 31, 2015 | 20.14M |
December 31, 2014 | 5.541M |
September 30, 2014 | 4.678M |
June 30, 2014 | 10.21M |
March 31, 2014 | 10.17M |
December 31, 2013 | 10.26M |
September 30, 2013 | 28.72M |
June 30, 2013 | 23.76M |
March 31, 2013 | 21.56M |
December 31, 2012 | 31.95M |
September 30, 2012 | 12.45M |
Date | Value |
---|---|
June 30, 2012 | 11.71M |
March 31, 2012 | 10.78M |
December 31, 2011 | 7.802M |
September 30, 2011 | 7.922M |
June 30, 2011 | 7.702M |
March 31, 2011 | 14.00M |
December 31, 2010 | 8.177M |
September 30, 2010 | 8.157M |
June 30, 2010 | 8.162M |
March 31, 2010 | 2.160M |
December 31, 2009 | 0.4746M |
September 30, 2009 | 0.4678M |
June 30, 2009 | 0.4627M |
March 31, 2009 | 0.00 |
December 31, 2008 | 0.00 |
September 30, 2008 | 0.00 |
June 30, 2008 | 0.00 |
March 31, 2008 | 3.788M |
December 31, 2007 | 4.892M |
September 30, 2007 | 5.111M |
June 30, 2007 | 5.068M |
March 31, 2007 | 1.262M |
December 31, 2006 | 1.558M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
CEL-SCI Corp | 8.678M |
AIM ImmunoTech Inc | 0.485M |
IGC Pharma Inc | 2.856M |
NovaBay Pharmaceuticals Inc | 1.91M |
Protalix BioTherapeutics Inc | 24.67M |